References
- Perlmutter A. Prostate heat treatments. Semin Urol 1992; 10: 169–79
- Devonec M, Tomera K, Perrin P. Review: transur-ethral microwave thermotherapy in benign pros-tatic hyperplasia. J Endourol 1993; 7: 255–8
- Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991; 145: 907–23
- Stamey TA, Yang N, Hay AR, McNeal IE, Freiha FS, Redwine E. Prostate-specific antigen as a marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909–16
- Kariyama M, Wang MC, Papsidero LD, et al. Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. Cancer Res 1980; 40: 4658–62
- Benson MC, Whang IS, Pantuck, et al. Prostate specific antigen density; a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992; 147: 815–6
- Siegel S. Nonparametric statistics for the behavioral sciences. McGraw-Hill Koga-kusha, Tokyo 1956
- Stamey TA. Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. Monogr Urol 1989; 10: 50–64
- Alivizatos G, Deliveliotis C, Karayiannis A, et al. Influence of digital examination, cystoscopy, transrectal ultrasonography and needle biopsy on the concentration of PSA. Proceedings of the 4th Mediterranean Congress of Urology. Rhodes 1995; 324
- Angelsen A, Hole A, Lundmo P, Romslo I. Digital rectal examination does not increase serum concentration of prostatic-specific antigen. Clin Chem 1992; 38: 782
- Crawford ED, Schutz MJ, Clejan S, et al. The effect of digital rectal examination on prostate-specific antigen levels. J Am Med Assoc 1992; 267: 2227–8
- Chybowski FM, Bergstralh EJ, Oesterling JE. The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study. J Urol 1992; 148: 83–6
- Devonec M, Ogden C, Perrin P, Carter S. Clinical response to transurethral microwave thermo-therapy is thermal dose dependent. Eur Urol 1993; 23: 267–14
- Eliasson TU, Abramsson LB, Petterson GT, Damber J-E. Responders and non-responders to treatment of benign prostatic hyperplasia with transurethral microwave thermotherapy. Scand J Urol Nephrol 1995; 29: 183–91
- Björk T, Abrahamsson P-A, Lilja H, Petterson K, Cockett ATK. Rates of clearance of free and complexed forms of PSA in serum after radical prostatectomy and transurethral microwave therapy. J Urol 1995; 153: 295A
- Christensson A, Björk T, Nilsson O, et al. Serum prostate specific antigen complexed to αl-antichymotrypsin as an indicator of prostate cancer. J Urol 1993; 150: 100–5
- Kaplan SA, Shabsigh R, Soldo KA, Olsson CA. Prostatic and periprostatic interstitial temperature measurements in patients treated with transrectal thermal therapy (local intracavitary microwave hyperthermia). J Urol 1992; 147: 1562–5
- Lindner A, Siegel YI, Korczak D. Serum prostate specific antigen levels during hyperthermia treatment of benign prostatic hyperplasia. J Urol 1990; 144: 1388–9
- Watson GM, Perlmutter A, Shah TK, Barnes DG. Heat treatment for severe, symptomatic prostatic outflow obstruction. World J Urol 1991; 9: 7–11
- Oesterling JE, Jacobsen SJ, Guess HA, Ginman CJ, Lieber M. Longitudinal changes in serum PSA (PSA velocity) in a community-based cohort of men. J Urol 1995; 153: 419A